SEC Tracker
Get the app
CVRX · XBRL financial data

CVRx financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (CVRX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Revenue from contracts with customers10,51111,305*10,77011,80713,37315,342*12,34813,58914,69016,024*14,76915,705
Cost of revenue1,6911,720*1,6151,9002,2482,571*2,0362,1391,9372,199*1,8881,981
Gross profit8,8209,585*9,1559,90711,12512,771*10,31211,45012,75313,825*12,88113,724
Research and development2,6962,241*3,0572,7652,5042,805*2,5172,4693,1463,000*3,0843,130
Selling, general and administrative15,65217,005*28,33021,11521,63220,240*21,23223,35721,87522,009*21,95823,617
Total operating expenses18,34819,246*31,38723,88024,13623,045*23,74925,82625,02125,009*25,04226,747
Operating income (loss)(9,528)(9,661)*(22,232)(13,973)(13,011)(10,274)*(13,437)(14,376)(12,268)(11,184)*(12,161)(13,023)
Interest expense499579*9609599581,520*1,4571,4731,4801,417*1,5511,578
Other income (expense)1,0561,116*1,0449449171,072*1,1231,110875660*593560
Income tax expense (benefit)4039*384147(71)*(5)(3)(3)(7)*13
Net income (loss)(9,011)(9,163)*(22,186)(14,029)(13,099)(10,651)*(13,766)(14,736)(12,870)(11,934)*(13,120)(14,044)
Earnings per share, basic USD per share(0.43)(0.44)*(1.04)(0.65)(0.57)(0.43)*(0.53)(0.57)(0.49)(0.46)*(0.50)(0.53)
Earnings per share, diluted USD per share(0.43)(0.44)*(1.04)(0.65)(0.57)(0.43)*(0.53)(0.57)(0.49)(0.46)*(0.50)(0.53)
Weighted average shares, basic thousands of shares20,80120,809*21,23221,62922,78324,716*25,87626,07126,16926,218*26,35626,515
Weighted average shares, diluted thousands of shares20,80120,809*21,23221,62922,78324,716*25,87626,07126,16926,218*26,35626,515

Balance sheet

CSV

Fiscal quarters (CVRX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents82,99390,56980,11570,400100,161105,933102,66895,02585,12475,70872,30364,586
Accounts receivable6,3727,5518,4958,6069,0339,2689,0127,1538,20910,6659,1049,401
Inventory10,88710,98311,05611,22411,89212,10711,67211,72011,39412,20512,40313,028
Prepaid and other current assets3,3452,9872,6561,7622,7862,5052,7822,2473,1633,0692,9402,473
Total current assets103,597112,090102,32291,992123,872129,813126,134116,145107,890101,64796,75089,488
Property and equipment, net1,7231,7632,5492,7632,6312,5052,4352,3452,4462,2432,1592,061
Right-of-use asset1,0581,3491,2741,2001,1441,0699941,048963878793708
Total assets106,404115,229106,17195,981127,673133,414129,589119,564111,325104,79499,72892,283
Accounts payable1,1331,8842,6083,5163,2762,5822,7513,0323,6283,8332,9983,874
Accrued liabilities6,2745,9805,7905,6107,6718,1805,7576,6577,5909,4846,4887,250
Total current liabilities7,4077,8648,3989,12610,94710,7628,5089,68911,21813,3179,48611,124
Long-term debt14,29429,22229,27029,31949,21449,27349,33249,39249,45349,51458,49058,571
Lease liability, non-current9161,1601,0921,023951877802819730638544448
Total liabilities23,57739,28239,91040,73362,49062,35960,22961,63063,27165,47070,61972,330
Accumulated deficit(468,218)(477,381)(499,567)(513,596)(526,695)(537,346)(551,112)(565,848)(578,718)(590,652)(603,772)(617,816)
Total stockholders' equity82,82775,94766,26155,24865,18371,05569,36057,93448,05439,32429,10919,953
Total liabilities and equity106,404115,229106,17195,981127,673133,414129,589119,564111,325104,79499,72892,283
Common shares outstanding (cover page) thousands of shares20,81620,92821,59621,78624,26426,03626,07326,15226,21026,31226,53626,642

Cash flows

CSV

Fiscal quarters (CVRX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(9,011)(9,163)*(22,186)(14,029)(13,099)(10,651)*(13,766)(14,736)(12,870)(11,934)*(13,120)(14,044)
Stock-based compensation1,532*1,590*11,1412,544*2,680*2,685*2,4552,916*2,888*2,793*2,9163,665*
Net cash from operating activities(8,125)*(7,839)*(10,896)(9,830)*(10,410)*(8,008)*(12,767)(7,936)*(9,709)*(9,758)*(12,164)(8,826)*
Purchases of property and equipment39*169*917355*37*52*114103*295*68*122112*
Net cash from investing activities(39)*(169)*(917)(355)*(37)*(52)*(114)(103)*(295)*(68)*(122)(112)*
Proceeds from issuing common stock0*0*547(1)*19,624*12,351*9,1980*(45)*(179)*(43)739*
Net cash from financing activities363*15,580*1,362472*40,202*13,834*9,615392*103*410*8,8821,221*
Net change in cash(7,822)*7,576*(10,454)(9,715)*29,761*5,772*(3,265)(7,643)*(9,901)*(9,416)*(3,405)(7,717)*

Compare with peers

SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($K)Revenue, quarter ($K)Operating cash flow, quarter ($K)Shares outstandingRunwayQuarter
CVRx64,58615,705(8,826)*26.6M7.3 quarters 10-QJun 30, 2026
LENSAR13,56516,495(127)*12.3M106.8 quarters 10-QJun 30, 2026
TriSalus Life Sciences46,28811,407(10,129)*61.6M4.6 quarters 10-QJun 30, 2026
KORU Medical Systems8,28812,045216*46.2M— 10-QJun 30, 2026
InfuSystem Holdings96436,9336,777*19.9M— 10-QJun 30, 2026
Shoulder Innovations24,46017,175(7,392)*20.8M13.4 quarters 10-QJun 30, 2026
Pulmonx52,69022,835(3,183)*43.6M8.5 quarters 10-QSep 30, 2026
Venus Concept4,31213,776(4,890)*1.9M0.9 quarters 10-QSep 30, 2025
Neuronetics19,19741,568(1,008)*76.2M19.0 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.